A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer

February 26, 2019
https://clinicaltrials.gov/ct2/results?id=NCT03742895
Solid Tumors, Cancer - Lymphoma
Principal Investigator: Ding Wang, MD
Homologous recombination repair mutation, homologous recombination deficiency, HRRm, HRD, previously treated
Accepting Participants